![]() |
市场调查报告书
商品编码
1904689
宠物处方粮市场预测至2032年:全球产品类型、宠物类型、成分、通路、应用、最终用户和区域分析Pet Prescription Diets Market Forecasts to 2032 - Global Analysis By Product (Dry Food, Treats, Wet Food, Veterinary Diets and Other Products), Pet Type, Ingredient, Distribution Channel, Application, End User and By Geography |
||||||
根据 Stratistics MRC 的一项研究,预计到 2025 年,全球宠物处方食品市场价值将达到 51.8 亿美元,到 2032 年将达到 81.6 亿美元,在预测期内的复合年增长率为 6.7%。
宠物处方粮是兽医营养产品,由专家监督专门配製,旨在帮助管理伴侣动物的特定健康问题。这些处方粮基于临床研究和营养科学研发,可解决消化系统疾病、肾臟疾病、肥胖、糖尿病、食物过敏和泌尿系统健康等问题。与一般宠物食品不同,处方粮的营养成分、特定食材和功能性添加剂均经过严格控制,有助于治疗和復原。我们秉承传统兽医学和现代科学的理念,并专注于为宠物提供预防保健、治疗支援和长期健康管理。
宠物慢性疾病呈上升趋势
伴侣动物慢性疾病的持续成长是推动宠物处方粮市场发展的核心因素。随着宠物寿命因照顾程度的提高和人类与动物之间情感纽带的加深而延长,肾臟疾病、肥胖、糖尿病和胃肠道疾病等也变得越来越常见。兽医越来越依赖经临床验证的营养干预措施作为第一线或辅助性治疗。营养疗法植根于多年的兽医经验,并藉助现代诊断技术进一步提升,使得处方营养成为宠物医疗保健中「必不可少」而非「可有可无」的组成部分。
处方饮食高成本
高成本是市场发展的一大限制因素,尤其是在价格敏感的地区。这些营养配方需要特殊的原料、严格的生产流程和广泛的临床检验,所有这些都导致了更高的价格。虽然传统兽医诊所推崇治疗性营养,但许多饲主面对持续的每月费用仍然犹豫不决。坦白说,经济负担往往决定了治疗的持续性。如果没有扩大保险覆盖范围或分级定价策略,成本障碍可能会阻碍其广泛应用。
配方创新
配方创新为市场持续成长带来了可喜的突破。营养科学的进步使得利用新型蛋白质、功能性纤维、益生菌和植物来源成分,可以研发出更精准、更具疾病特异性的配方。人们越来越关注偏好、消化率和洁净标示配方,这些配方融合了现代科学技术,同时也体现了传统的饲养理念。客製化、品种特异性配方以及兼具治疗和预防功能的混合配方正变得越来越普遍。将成熟的兽医学原理与前沿创新相结合的公司,将更有可能赢得持久的信任和市场份额。
监管和标籤方面的挑战
监管和标籤的复杂性对市场稳定构成持续威胁。处方粮必须符合严格的兽医、营养和安全标准,而这些标准因地区而异。标籤错误、前后矛盾的宣传以及违反监管规定会迅速损害消费者信任,并导致处罚。随着市场日趋成熟,监管机构正在加强监管,以保护动物健康。企业必须投资于透明的标籤、可靠的临床证据以及对法规的严格遵守,才能生存和发展。反过来,这也构成了市场扩张的障碍。
新冠疫情对市场产生了复杂而深远的影响。供应链中断最初导致生产和分销放缓,而兽医就诊限制则造成了诊断和饮食调整的延误。然而,居家隔离令加强了宠物饲养和情感纽带,促使饲主更加重视宠物的长期健康照护。电子商务和远端兽医咨询服务蓬勃发展,重塑了分销模式。回望过去,这场危机再次印证了「宠物是家人」这一长久以来的真理,同时也加速了现代通路的发展,这些管道将定义后疫情时代的增长。
预计在预测期内,蔬菜细分市场将占据最大的市场份额。
由于其功能性和治疗价值,预计蔬菜将在预测期内占据最大的市场份额。蔬菜提供必需的膳食纤维、抗氧化剂和微量营养素,有助于消化健康、体重管理和代谢平衡。植物来源成分长期以来在兽医营养领域备受信赖,如今正透过临床研究不断改进,以应对特定疾病。它们非常适合併融入肾臟病、糖尿病和胃肠道疾病的饮食方案中。随着人们对清洁、天然和易消化成分的需求日益增长,蔬菜已稳固确立了其核心地位。
预计在预测期内,兽医院板块的复合年增长率将最高。
由于兽医诊所在诊断营养管理中发挥核心作用,预计在预测期内,兽医诊所板块将实现最高的成长率。处方粮传统上是在临床环境中引入和使用的,而信任和专业权威至关重要。随着诊所采用整合诊断、治疗和营养管理的护理模式,营养疗法将成为常规程序。宠物保险的普及和预防性护理就诊次数的增加将进一步推动成长。在一个信任至关重要的市场中,兽医诊所仍然是扩张的最强驱动力。
亚太地区预计将在整个预测期内占据最大的市场份额,这主要得益于快速的都市化、不断增长的可支配收入以及日益普及的宠物饲养率。中国、日本和印度等国家正经历从基础宠物餵食到以医疗为指导的营养管理的转变。人们对兽医建议的传统信任以及日益增强的预防保健意识正在推动这一转变。随着当地企业与全球品牌合作,该地区正将传统的关怀理念与现代营养科学结合,从而巩固主导地位。
在预测期内,北美地区预计将实现最高的复合年增长率,这主要得益于其先进的兽医基础设施和高昂的宠物医疗保健支出。该地区的宠物饲主愿意将处方粮作为疾病管理和预防保健的一部分。健全的法规结构、普及的宠物保险以及对创新技术的早期应用也是推动成长的因素。北美地区根深蒂固的务实概念认为,如果营养能改善生活质量,那么投入的资金就是值得的。这种理念,加上持续的产品创新,正助力北美市场维持快速成长。
According to Stratistics MRC, the Global Pet Prescription Diets Market is accounted for $5.18 billion in 2025 and is expected to reach $8.16 billion by 2032 growing at a CAGR of 6.7% during the forecast period. Pet Prescription Diets are specially formulated veterinary nutrition products designed to support the management of specific medical conditions in companion animals under professional supervision. Developed using clinical research and nutritional science, these diets address issues such as digestive disorders, kidney disease, obesity, diabetes, food allergies, and urinary health. Unlike standard pet foods, prescription diets contain carefully controlled nutrient profiles, targeted ingredients, and functional additives to aid treatment and recovery. Rooted in traditional veterinary practice and modern science, they emphasize preventive care, therapeutic support, and long-term health management for pets.
Growing Prevalence of Chronic Pet Diseases
The steady rise in chronic conditions among companion animals is a central force pushing the pet prescription diets market forward. As pets live longer due to better care and closer human-animal bonds ailments such as kidney disease, obesity, diabetes, and gastrointestinal disorders have become more common. Veterinarians increasingly rely on clinically proven nutritional interventions as first-line or supportive therapy. Rooted in long-standing veterinary wisdom, diet-based management is now reinforced by modern diagnostics, making prescription nutrition an essential, not optional, component of pet healthcare.
High Cost of Prescription Diets
High costs remain a stubborn restraint in the market, particularly in price-sensitive regions. These diets demand specialized ingredients, controlled manufacturing processes, and extensive clinical validation, all of which drive up prices. While traditional veterinary practice supports therapeutic feeding, many pet owners still hesitate when faced with recurring monthly expenses. The reality is blunt affordability often dictates compliance. Without broader insurance coverage or tiered pricing strategies, cost barriers may limit adoption.
Innovation in Formulations
Innovation in formulations presents a promising opening for sustained market growth. Advances in nutritional science are enabling more precise, condition-specific diets using novel proteins, functional fibers, probiotics, and plant-based ingredients. There is growing emphasis on palatability, digestibility, and clean-label formulations that echo traditional feeding values while embracing modern science. Customization, breed-specific diets, and hybrid therapeutic-preventive formulations are gaining ground. Companies that balance time-tested veterinary principles with forward looking innovation stand to earn lasting trust and market share.
Regulatory & Labeling Challenges
Regulatory and labeling complexities pose a persistent threat to market stability. Prescription diets must meet stringent veterinary, nutritional, and safety standards that vary across regions. Mislabeling, inconsistent claims, or regulatory non-compliance can quickly erode credibility and invite penalties. As markets mature, authorities are tightening oversight to protect animal health. Companies must invest in transparent labeling, robust clinical backing, and regulatory diligence to survive and scale. Thus, it hinders market expansion.
The COVID-19 pandemic left a mixed but lasting imprint on the market. Supply chain disruptions initially slowed production and distribution, while restricted veterinary visits delayed diagnoses and diet transitions. Yet confinement also strengthened pet ownership and emotional attachment, pushing owners to prioritize long-term health. E-commerce and tele-veterinary consultations gained traction, reshaping distribution models. In hindsight, the crisis reinforced a traditional truth pets are family while accelerating modern channels that now define post-pandemic growth.
The vegetables segment is expected to be the largest during the forecast period
The vegetables segment is expected to account for the largest market share during the forecast period, due to its functional and therapeutic value. Vegetables provide essential fibers, antioxidants, and micronutrients that support digestive health, weight management, and metabolic balance. Long trusted in veterinary nutrition, plant-based components are now refined through clinical research to target specific conditions. Their compatibility with renal, diabetic, and gastrointestinal diets makes them indispensable. As demand rises for clean, natural, and easily digestible ingredients, vegetables hold firm at the core.
The veterinary clinics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the veterinary clinics segment is predicted to witness the highest growth rate, due to their central role in diagnosis-driven nutrition. Prescription diets are traditionally introduced and monitored within clinical settings, where trust and professional authority matter most. As clinics adopt integrated care models-combining diagnostics, treatment, and nutrition dietary therapy becomes routine. Rising pet insurance coverage and preventive care visits further support growth. In a market where credibility is currency, veterinary clinics remain the strongest engine of expansion.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rapid urbanization, rising disposable incomes, and expanding pet ownership. Countries such as China, Japan, and India are witnessing a shift from basic pet feeding to medically guided nutrition. Traditional respect for veterinary advice, combined with growing awareness of preventive healthcare, supports adoption. As local players partner with global brands, the region blends long-standing care values with modern nutritional science, anchoring its market leadership.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced veterinary infrastructure and high pet healthcare spending. Pet owners in the region readily accept prescription diets as part of disease management and preventive care. Strong regulatory frameworks, widespread pet insurance, and early adoption of innovation fuel growth. The culture is frank and practical if nutrition improves quality of life, it's worth the cost. This mindset, paired with continuous product innovation, keeps North America on a fast upward track.
Key players in the market
Some of the key players in Pet Prescription Diets Market include Hill's Pet Nutrition, WellPet LLC, Royal Canin, Arden Grange, Purina Pro Plan Veterinary Diets, Kemin Industries, Iams Veterinary Formulas, Elanco Animal Health, Eukanuba Veterinary Diets, Zoetis Inc., Farmina Pet Foods, Spectrum Brands Holdings, Virbac, Blue Buffalo Natural Veterinary Diet and Dechra Pharmaceuticals.
In June 2025, Zoetis has signed a strategic consulting deal with global IT firm Infosys to boost its digital capabilities and IT operations. Under the long-term engagement, Infosys will integrate advanced AI and automation solutions to enhance agility, improve operational efficiency, and better support veterinarians, livestock producers, and pet owners worldwide.
In December 2025, Zoetis and Colorado State University's AgNext have launched a strategic cattle research collaboration to deepen scientific understanding of sustainable livestock production. The partnership will gather baseline data on greenhouse gas emissions and conduct lifecycle assessments to inform better animal health, in response to evolving sustainability goals.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.